138 related articles for article (PubMed ID: 35689585)
1. Preoperative chemotherapy is a better strategy than upfront surgery in cT4 gastric cancer.
Dias AR; Pereira MA; Ramos MFKP; Ribeiro U; Zilberstein B; Nahas SC
J Surg Oncol; 2022 Jul; 126(1):132-138. PubMed ID: 35689585
[TBL] [Abstract][Full Text] [Related]
2. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
3. PREOPERATIVE CHEMOTHERAPY VERSUS UPFRONT SURGERY FOR ADVANCED GASTRIC CANCER: A PROPENSITY SCORE MATCHING ANALYSIS.
Hong S; Pereira MA; Victor CR; Gregório JVA; Zilberstein B; Ribeiro Junior U; D'albuquerque LAC; Ramos MFKP
Arq Bras Cir Dig; 2023; 36():e1736. PubMed ID: 37436207
[TBL] [Abstract][Full Text] [Related]
4. Radical D2 gastrectomy with adjuvant chemotherapy for stage IB/II/III distal gastric cancers in the era of perioperative chemotherapy: A propensity matched comparison.
Singh HK; Chaudhari V; Batra S; Ostwal V; Ramaswamy A; Mokal S; Shrikhande SV; Bhandare MS
Am J Surg; 2022 Jun; 223(6):1055-1062. PubMed ID: 34756584
[TBL] [Abstract][Full Text] [Related]
5. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
8. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
9. The Addition of Chemoradiation to Adjuvant Chemotherapy is Associated With Improved Survival Following Upfront Surgical Resection for Pancreatic Cancer With Nodal Metastases.
Altman AM; White MJ; Marmor S; Shukla D; Chang K; Lou E; LaRocca CJ; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
Cancer Control; 2022; 29():10732748221109991. PubMed ID: 35839251
[TBL] [Abstract][Full Text] [Related]
10. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy.
Badgwell B; Ajani J; Blum M; Ho L; Fournier K; Chiang YJ; Matamoros A; Das P; Mansfield P
Ann Surg Oncol; 2016 Jan; 23(1):156-62. PubMed ID: 26059652
[TBL] [Abstract][Full Text] [Related]
12. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
13. Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective, comparative study at a single tertiary care institute.
Sun LB; Zhao GJ; Ding DY; Song B; Hou RZ; Li YC
World J Surg Oncol; 2014 Sep; 12():280. PubMed ID: 25200958
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
16. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
[TBL] [Abstract][Full Text] [Related]
17. Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
Margalit O; Yu S; Shacham-Shmueli E; Strauss G; Yang YX; Lawrence YR; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Mamtani R; Boursi B
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1703-1708. PubMed ID: 35066662
[TBL] [Abstract][Full Text] [Related]
18. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.
Li ZY; Shan F; Zhang LH; Bu ZD; Wu AW; Wu XJ; Zong XL; Wu Q; Ren H; Ji JF
World J Surg Oncol; 2011 Sep; 9():110. PubMed ID: 21942969
[TBL] [Abstract][Full Text] [Related]
19. Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients.
Sędłak K; Rawicz-Pruszyński K; Mlak R; Gęca K; Skórzewska M; Pelc Z; Małecka-Massalska T; Polkowski WP
Eur J Surg Oncol; 2022 Feb; 48(2):356-361. PubMed ID: 34404560
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?
Ramos MFKP; Pereira MA; Amorim LC; de Mello ES; Faraj SF; Ribeiro U; Hoff PMG; Cecconello I; de Castria TB
J Surg Oncol; 2020 Apr; 121(5):804-813. PubMed ID: 31797380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]